Hyperimmune bovine colostrum for treatment of GI infections: A review and update on clostridium difficile

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 7, 2013, Pages 1565-1568

  Steele, Jennifer ^a   Sponseller, Jerlyn ^a   Schmidt, Diane ^a   Cohen, Ocean ^a   Tzipori, Saul ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Clostridium difficile; Diarrhea; Gastrointestinal infection; Hyperimmune bovine colostrum; Prevention; Treatment

Indexed keywords

FIDAXOMICIN; IMMUNOGLOBULIN G ANTIBODY; METRONIDAZOLE; RECOMBINANT VACCINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; COLOSTRUM; CONFERENCE PAPER; CRYPTOSPORIDIOSIS; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; GASTROINTESTINAL INFECTION; HEALTH CARE COST; HUMAN; HYPERIMMUNE BOVINE COLOSTRUM; INFECTION PREVENTION; ROTAVIRUS INFECTION; THERAPY EFFECT; TREATMENT INDICATION; UREA BREATH TEST;

CLOSTRIDIUM DIFFICILE; DIARRHEA; GASTROINTESTINAL INFECTION; HYPERIMMUNE BOVINE COLOSTRUM; PREVENTION; TREATMENT;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CATTLE; CLOSTRIDIUM DIFFICILE; COLOSTRUM; CRYPTOSPORIDIOSIS; DYSENTERY, BACILLARY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOLOGIC FACTORS; ROTAVIRUS INFECTIONS; VACCINES, SYNTHETIC;

EID: 84880899231     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24078     Document Type: Conference Paper

References (35)

1. Tzipori S, Roberton D, Chapman C. Remission of diarrhoea due to cryptosporidiosis in an immuno-deficient child treated with hyperimmune bovine colostrum. Br Med J (Clin Res Ed) 1986; 293:1276-7; PMID:3096462; http://dx.doi.org/10.1136/bmj.293.6557.1276.
2. Tzipori S, Roberton D, Cooper DA, White L. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet 1987; 2:344-5; PMID:2886815; http://dx.doi.org/10.1016/S0140-6736(87)90944-5.
3. Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:348-54; PMID:8948373; http://dx.doi.org/10.1097/00042560-199612010-00008.
4. Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 1998; 26:1324-9; PMID:9636857; http://dx.doi.org/10.1086/516374.
5. Tacket CO, Binion SB, Bostwick E, Losonsky G, Roy MJ, Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg 1992; 47:276-83; PMID:1524140.
6. Ashraf H, Mahalanabis D, Mitra AK, Tzipori S, Fuchs GJ. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a doubleblind, randomized, controlled trial. Acta Paediatr 2001; 90:1373-8; PMID:11853331; http://dx.doi.org/10.1111/j.1651-2227.2001.tb01598.x.
7. Opekun AR, El-Zaimaity HM, Osato MS, Gilger MA, Malaty HM, Terry M, et al. Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 1999; 13:35-42; PMID:9892877; http://dx.doi.org/10.1046/j.1365-2036.1999.00435. x.
8. Casswall TH, Sarker SA, Albert MJ, Fuchs GJ, Bergström M, Björck L, et al. Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther 1998; 12:563-8; PMID:9678817; http://dx.doi.org/10.1046/ j.1365-2036.1998.00335.x.
9. Hilpert H, Brüssow H, Mietens C, Sidoti J, Lerner L, Werchau H. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 1987; 156:158-66; PMID:3110303; http://dx.doi.org/10.1093/infdis/156.1.158.
10. Mitra AK, Mahalanabis D, Ashraf H, Unicomb L, Eeckels R, Tzipori S. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double- blind, controlled clinical trial. Acta Paediatr 1995; 84:996-1001; PMID:8652974; http://dx.doi.org/10.1111/j.1651-2227.1995.tb13814.x.
11. Davidson GP, Whyte PB, Daniels E, Franklin K, Nunan H, McCloud PI, et al. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 1989; 2:709-12; PMID:2570959; http://dx.doi.org/10. 1016/S0140-6736(89)90771-X.
12. Turner RB, Kelsey DK. Passive immunization for prevention of rotavirus illness in healthy infants. Pediatr Infect Dis J 1993; 12:718-22; PMID:8414797; http://dx.doi.org/10.1097/00006454-199309000-00003.
13. Tacket CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 1988; 318:1240-3; PMID:3283555; http://dx.doi.org/10.1056/NEJM198805123181904.
14. Freedman DJ, Tacket CO, Delehanty A, Maneval DR, Nataro J, Crabb JH. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis 1998; 177:662-7; PMID:9498445; http://dx.doi.org/10.1086/ 514227.
15. Otto W, Najnigier B, Stelmasiak T, Robins-Browne RM. Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scand J Gastroenterol 2011; 46:862-8; PMID:21526980; http://dx.doi.org/10.3109/00365521. 2011.574726.
16. Tawfeek HI, Najim NH, Al-Mashikhi S. Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: a field trial. Int J Infect Dis 2003; 7:120-8; PMID:12839713; http://dx.doi.org/10.1016/S1201-9712(03)90007-5.
17. Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 2009; 58:403-10; PMID:19394704; http://dx.doi.org/10.1016/j.jinf.2009.03.010.
18. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15:573-81; PMID:1420669; http://dx.doi.org/10.1093/clind/15.4.573.
19. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55(Suppl 2):S88-92; PMID:22752870; http://dx.doi.org/10.1093/cid/cis335.
20. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012; 55:216-23; PMID:22491338; http://dx.doi.org/10.1093/cid/cis386.
21. Johnson AP, Wilcox MH. Fidaxomicin: a new option for the treatment of Clostridium difficile infection. J Antimicrob Chemother 2012; 67:2788-92;PMID:22865382; http://dx.doi.org/10.1093/jac/dks302.
22. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38:2386-8; PMID:10835010.
23. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010; 74:309-18; PMID:20153547; http://dx.doi.org/10.1016/j.jhin.2009.10.016.
24. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40:1591-7; PMID:15889355; http://dx.doi.org/10.1086/430315.
25. Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 2012; 50:4078-82; PMID:23052318; http://dx.doi.org/10.1128/JCM.02291- 12.
26. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and casefatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14:929-31; PMID:18507904; http://dx.doi.org/ 10.3201/eid1406.071447.
27. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171:466-72; PMID:15337727; http://dx.doi.org/10.1503/cmaj.1041104.
28. Naaber P, Lehto E, Salminen S, Mikelsaar M. Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunol Med Microbiol 1996; 14:205-9; PMID:8856319; http://dx.doi.org/10.1111/j.1574-695X.1996.tb00288.x.
29. Lyerly DM, Bostwick EF, Binion SB, Wilkins TD. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991; 59:2215-8; PMID:2037383.
30. Kelly CP, Chetham S, Keates S, Bostwick EF, Roush AM, Castagliuolo I, et al. Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrob Agents Chemother 1997; 41:236-41; PMID:9021173.
31. Warny M, Fatimi A, Bostwick EF, Laine DC, Lebel F, LaMont JT, et al. Bovine immunoglobulin concentrate-clostridium difficile retains C. difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut 1999; 44:212-7; PMID:9895380; http://dx.doi.org/10.1136/gut.44.2. 212.
32. Mattila E, Anttila VJ, Broas M, Marttila H, Poukka P, Kuusisto K, et al. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis 2008; 40:702-8; PMID:19086244; http://dx.doi.org/10.1080/00365540801964960.
33. Numan SC, Veldkamp P, Kuijper EJ, van den Berg RJ, van Dissel JT. Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut 2007; 56:888-9; PMID:17519495; http://dx.doi.org/10.1136/gut.2006.119016.
34. Wang H, Sun X, Zhang Y, Li S, Chen K, Shi L, et al. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect Immun 2012; 80:2678-88; PMID:22615245; http://dx.doi.org/10.1128/IAI. 00215-12.
35. Steele J, Feng H, Parry N, Tzipori S. Piglet models of acute or chronic Clostridium difficile illness. J Infect Dis 2010; 201:428-34; PMID:20039803; http://dx.doi.org/10.1086/649799.